Cargando…
Insulin B-chain hybrid peptides are agonists for T cells reactive to insulin B:9-23 in autoimmune diabetes
Insulin is considered to be a key antigenic target of T cells in Type 1 Diabetes (T1D) and autoimmune diabetes in the NOD mouse with particular focus on the B-chain amino acid sequence B:9-23 as the primary epitope. Our lab previously discovered that hybrid insulin peptides (HIPs), comprised of insu...
Autores principales: | Wenzlau, Janet M., DiLisio, James E., Barbour, Gene, Dang, Mylinh, Hohenstein, Anita C., Nakayama, Maki, Delong, Thomas, Baker, Rocky L., Haskins, Kathryn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399855/ https://www.ncbi.nlm.nih.gov/pubmed/36032090 http://dx.doi.org/10.3389/fimmu.2022.926650 |
Ejemplares similares
-
Induction of Antigen-Specific Tolerance in Autoimmune Diabetes with Nanoparticles Containing Hybrid Insulin Peptides
por: DiLisio, James E., et al.
Publicado: (2021) -
Characterization of Human CD4 T Cells Specific for a C-Peptide/C-Peptide Hybrid Insulin Peptide
por: Wiles, Timothy A., et al.
Publicado: (2021) -
Hybrid Insulin Peptides Are Autoantigens in Type 1 Diabetes
por: Baker, Rocky L., et al.
Publicado: (2019) -
Hybrid insulin peptide isomers spontaneously form in pancreatic beta-cells from an aspartic anhydride intermediate
por: Crawford, Samantha A., et al.
Publicado: (2023) -
Hybrid Insulin Peptides Are Recognized by Human T Cells in the Context of DRB1*04:01
por: Arribas-Layton, David, et al.
Publicado: (2020)